SELECTBIO Conferences Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019
Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019
Date: October 30 - November 1, 2019
Venue: Rotterdam Marriott, Rotterdam, The Netherlands

Conference Chair

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor, University Medical Center Utrecht

Keynote Speakers

Lorena Dieguez

Lorena Dieguez
Leader of the Medical Devices Research Group, INL- International Iberian Nanotechnology Laboratory

Esther Nolte-‘t Hoen

Esther Nolte-‘t Hoen
Assistant Professor, Department of Biochemistry & Cell Biology, Faculty of Veterinary Medicine, Utrecht University

Patrizia Paterlini-Brechot

Patrizia Paterlini-Brechot
Professor of Oncology/Molecular Biology, University Paris Descartes

Takahiro Ochiya

Takahiro Ochiya
Chief, National Cancer Center Research Institute Japan

Leon Terstappen

Leon Terstappen
Chair Medical CellBiophysics, MIRA Research Institute for Biomedical Technology and Technical Medicine, University of Twente

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Graham Pockley

Graham Pockley
Director and Professor, John van Geest Cancer Research Centre, Nottingham Trent University, CEO, multimmune GmbH

Overview

SELECTBIO welcomes you to Exosomes and Liquid Biopsy Europe 2019 to be held in Rotterdam, The Netherlands.

This annual conference now in its Fourth Year brings together academics and industry participants from around the world focused on research, biomarker analyses and therapeutics development leveraging the cargo from Exosomes and Extracellular Vesicles (EVs).

An important component of this conference is to focus upon the development of liquid biopsies utilizing circulating cell-free DNA (cfDNA), circulating tumour cells (CTCs) and other biomarkers found in biofluids.

Presentations, Panel Discussions and Round-Table Workshops from key opinion leaders in the field form the basis of this conference and companies/vendors in the space participate to showcase their most up-to-date product and service offerings.

Rotterdam is an excellent host city for this conference with its excellent infrastructure, fast connections across Europe and easy access from around the World via Amsterdam-Schiphol.

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 21 October 2019

Agenda Topics

  • Circulating Cell-Free DNA (cfDNA) for Liquid Biopsy Development
    • Companies Showcase
    • Technologies for Mutation Detection and Analysis
  • Circulating Tumour Cells (CTCs) for Liquid Biopsy Development
    • Companies Showcase
    • Emerging Technology Trends
  • Exosomes and Extracellular Vesicles (EV) Biomarker Potential
    • Proteins, DNA and Lipids
    • RNA Cargo
  • Exosomes and Extracellular Vesicles (EV) Research Trends
  • Exosomes and Extracellular Vesicles (EV) Studies in Various Diseases
    • Cancer
    • Cardiovascular Disease
    • CNS Disease
  • Isolation and Characterization of Exosomes and EV Classes
  • Modification and Engineering of Exosomes and EVs
  • Therapeutics Opportunities: Targeting using Exosomes/EVs

Sponsorship and Exhibition Opportunities

For more details, please contact us.

Confirmed Speakers to date

Dimitri Aubert, VP Sales and Marketing, Managing Director Europe, NanoFCM
CJ Barnum, Director of Neuroscience, INmune Bio, Inc.
Alain Brisson, Professor Emeritus, University of Bordeaux
Clotilde Costa, Leader of the Liquid Biopsy Line, Joint Unit Roche-Chus, Oncomet, Universitary Cinical Hospital of Santiago de Compostela
Peter Djali, European Sales Director, IsoPlexis
Francoise Farace, Head of Rare Circulating Cells Translational Laboratory, INSERM Gustave Roussy Institute
Michael Graner, Associate Professor, Dept of Neurosurgery, University of Colorado Anschutz School of Medicine
Jens Habermann, Head, Section of Translational Surgical Oncology and Biobanking & Scientific Director, Surgical Center for Translational Oncology, Department of Surgery & Institute of Human Genetics, University of Lubeck and University Hospital Schleswig-Holstein, Campus Lubeck
Mark Harmon, Field Applications Specialist, Oxford Nanoimaging (ONI)
Robert Hartley, Sales Manager, MMI - Molecular Machines and Industries
An Hendrix, Professor, Ghent University
Florent Mouliere, Assistant Professor, Cancer Center Amsterdam, VUMC Amsterdam
Christa Noehammer, Senior Scientist, Austrian Institute of Technology
Ben Owen, Regional Sales Director, NanoView Biosciences, Inc.
Michiel Pegtel, Associate Professor, Cancer Center Amsterdam, VU University Medical Center
Michael Pfaffl, Professor, Technical University of Munich
Anders Stahlberg, Associate Professor, Sahlgrenska Cancer Center, University of Gothenburg
Nikolas Stoecklein, Professor, University of Dusseldorf
Valerie Taly, CNRS Research Director, Group leader Translational Research and Microfluidics, University Paris Descartes
RJ Tesi, CEO/CMO, Inmune Bio Inc
Jo Vandesompele, Professor, Ghent University and CSO, Biogazelle
Bas WM van Balkom, Assistant Professor, University Medical Center Utrecht
Yagmur Yildizhan, Researcher, Biosensors Group, KU Leuven


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Update History
2019/09/02
Speaker,Sponsor updated
2019/07/31
Agenda,Speaker updated
2019/07/12
Agenda,Speaker updated
2019/06/14
Speaker updated